Episode 2 is a special one for me. This is an interview recorded in late 2021 with Professor David Nutt, a man who has been at the forefront of research into psychedelics, cannabis, MDMA, tobacco and alcohol for almost 4 decades. His work is not only fascinating but unbelievably important and could lead to a revolution in how we think about drugs, but more importantly, how we can use them to help people. We also cover politics, policy, history, how challenging undertaking research in this field can be, and more. Thanks for listening!More Medlife Crisis:https://twitter.com/medcrisishttps://www.youtube.com/medlifecrisishttps://www.youtube.com/@medlife2https://watchnebula.com/medlifecrisishttps://www.instagram.com/medcrisisThe Drug Science charity, independent unbiased drug information: https://www.drugscience.org.uk/Check out the Drug Science podcast as well https://open.spotify.com/show/2hLSRIS777SKphWxv4HyDKReferences mentioned:Trial of Psilocybin versus Escitalopram for Depression https://www.nejm.org/doi/full/10.1056/NEJMoa2032994Self-blinding citizen science to explore psychedelic microdosing https://elifesciences.org/articles/62878 Hosted on Acast. See acast.com/privacy for more information.

Ver todos los episodios